Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arnaud Friggeri

Showing results (71-80 of 94) with videos related to

Pageof 10
Sort By:
Antimicrobial Agents and Chemotherapy|September 26, 2024
Parametric and nonparametric population pharmacokinetic analysis of fluconazole in critically ill patients and dosing simulations for <i>Candida</i> infectionsElodie Matusik, Olivia Vassal, Anne Conrad, et al.
Human Immunology|March 26, 2017
Modulation of LILRB2 protein and mRNA expressions in septic shock patients and after ex vivo lipopolysaccharide stimulationFabienne Venet, Jeremy Schilling, Marie-Angélique Cazalis, et al.
Intensive Care Medicine|September 23, 2025
Monocyte HLA-DR expression in septic shock patients: insights from a 20-year real-world cohort of 1023 casesGuillaume Monneret, Thomas Lafon, Morgane Gossez, et al.
Emerging Infectious Diseases|September 1, 2021
Co-infection with Legionella and SARS-CoV-2, France, March 2020Camille Allam, Alexandre Gaymard, Ghislaine Descours, et al.
Anaesthesia, Critical Care & Pain Medicine|May 3, 2016
Anxiety and stress among anaesthesiology and critical care residents during high-fidelity simulation sessionsChristian Bauer, Thomas Rimmelé, Antoine Duclos, et al.
Annals of Intensive Care|May 12, 2024
Cefiderocol in Difficult-to-Treat Nf-GNB in ICU SettingsCharles-Hervé Vacheron, Anne Kaas, Jean-Philippe Rasigade, et al.
Critical Care (London, England)|December 4, 2015
Putative invasive pulmonary aspergillosis in critically ill patients with chronic obstructive pulmonary disease: a matched cohort studyClaire Delsuc, Aurélie Cottereau, Emilie Frealle, et al.
Critical Care (London, England)|April 5, 2022
Intensive care-related loss of quality of life and autonomy at 6 months post-discharge: Does COVID-19 really make things worse?Fabrice Thiolliere, Claire Falandry, Bernard Allaouchiche, et al.
Fundamental & Clinical Pharmacology|April 17, 2018
Determinants of amikacin first peak concentration in critically ill patientsClément Boidin, Sophie Jenck, Laurent Bourguignon, et al.
American Journal of Respiratory and Critical Care Medicine|May 10, 2022
Attributable Mortality of Ventilator-associated Pneumonia Among Patients with COVID-19Charles-Hervé Vacheron, Alain Lepape, Anne Savey, et al.
Pageof 10

Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
Antimicrobial Agents and Chemotherapy|September 26, 2024
Parametric and nonparametric population pharmacokinetic analysis of fluconazole in critically ill patients and dosing simulations for <i>Candida</i> infectionsElodie Matusik, Olivia Vassal, Anne Conrad, et al.
Human Immunology|March 26, 2017
Modulation of LILRB2 protein and mRNA expressions in septic shock patients and after ex vivo lipopolysaccharide stimulationFabienne Venet, Jeremy Schilling, Marie-Angélique Cazalis, et al.
Intensive Care Medicine|September 23, 2025
Monocyte HLA-DR expression in septic shock patients: insights from a 20-year real-world cohort of 1023 casesGuillaume Monneret, Thomas Lafon, Morgane Gossez, et al.
Emerging Infectious Diseases|September 1, 2021
Co-infection with Legionella and SARS-CoV-2, France, March 2020Camille Allam, Alexandre Gaymard, Ghislaine Descours, et al.
Anaesthesia, Critical Care & Pain Medicine|May 3, 2016
Anxiety and stress among anaesthesiology and critical care residents during high-fidelity simulation sessionsChristian Bauer, Thomas Rimmelé, Antoine Duclos, et al.
Annals of Intensive Care|May 12, 2024
Cefiderocol in Difficult-to-Treat Nf-GNB in ICU SettingsCharles-Hervé Vacheron, Anne Kaas, Jean-Philippe Rasigade, et al.
Critical Care (London, England)|December 4, 2015
Putative invasive pulmonary aspergillosis in critically ill patients with chronic obstructive pulmonary disease: a matched cohort studyClaire Delsuc, Aurélie Cottereau, Emilie Frealle, et al.
Critical Care (London, England)|April 5, 2022
Intensive care-related loss of quality of life and autonomy at 6 months post-discharge: Does COVID-19 really make things worse?Fabrice Thiolliere, Claire Falandry, Bernard Allaouchiche, et al.
Fundamental & Clinical Pharmacology|April 17, 2018
Determinants of amikacin first peak concentration in critically ill patientsClément Boidin, Sophie Jenck, Laurent Bourguignon, et al.
American Journal of Respiratory and Critical Care Medicine|May 10, 2022
Attributable Mortality of Ventilator-associated Pneumonia Among Patients with COVID-19Charles-Hervé Vacheron, Alain Lepape, Anne Savey, et al.
Pageof 10